Riskpilot← Back to searchSign inGet full accessFysida AB
ABActiveOrg 5568827900Galoppstigen 14 DPhysiotherapy activities · NACE 8695Est. 20120 employees
Revenue 2025
SEK 1,3M
+20% vs 2024
EBITDA margin
-6.6%
+69% vs 2024
Equity ratio
47.9%
Financial strength
Net profit 2025
SEK -90K
+68% vs 2024
| Revenue | SEK 1,3M | +20% |
| EBITDA | SEK -89K | +69% |
| Net profit | SEK -90K | +68% |
| Total assets | SEK 238K | -22% |
| Equity | SEK 114K | -44% |
| Employees | 0 | — |
Legal name
Fysida AB
Org number
5568827900
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
31 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att beriva öppen hälsovård och sjukvård, föreläsning inom hälso- och sjukvård, sjukgymna- stik, rehabilitering, personlig tränare samt därmed förenlig verksamhet.
Address
Galoppstigen 14 D
Phone
+4654212060
Email
ida@solakliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 486 | 1 234 | 894 | 1 118 | 1 346 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 365 | 22 | −235 | −284 | −89 |
| Depreciation & amort. | −6 | −6 | −6 | −0 | −0 |
| EBIT | 359 | 16 | −241 | −284 | −89 |
| Net financials | — | −1 | 1 | 1 | −1 |
| Profit before tax | 268 | 92 | −149 | −284 | −90 |
| Tax | −60 | −20 | −1 | −0 | −0 |
| Net profit | 208 | 72 | −150 | −284 | −90 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 047 | 920 | 738 | 304 | 238 |
| Equity | 667 | 738 | 588 | 205 | 114 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 212 | 91 | 149 | 100 | 123 |
| Total debt | 212 | 91 | 149 | 100 | 123 |
EBITDA margin
-6.6%
This company
15.8%
Market median
-142% vs market
20212025
Equity ratio
47.9%
This company
38.2%
Market median
+25% vs market
20212025
Return on equity
-78.9%
This company
18.4%
Market median
-529% vs market
20212025
Net profit margin
-6.7%
This company
8.1%
Market median
-183% vs market
20212025
Asset turnover
5.66×
This company
1.12×
Market median
+405% vs market
20212025
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Audit | 2022 | |
KI Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2026 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fysida AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eriknils Anders Thomas Karlsson | Audit | 0 companies |
| Karin Ida Marie Thomasdotter | Chief Executive Officer | 0 companies |
| Anna Kristina Maria Andersson | Deputy Board Member | 0 companies |
| Per Erik Urban Nilsson | Deputy Board Member | 0 companies |